{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:24:28Z","timestamp":1766690668807},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038896","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T21:02:20Z","timestamp":1339534940000},"page":"e38896","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of a Multiparametric Immunofluorescence Assay for Standardization of Neuromyelitis Optica Serology"],"prefix":"10.1371","volume":"7","author":[{"given":"Letizia","family":"Granieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Marnetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Frau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata Katia","family":"Patanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Nytrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Sola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome).","volume":"53(5)","author":"DM Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2006.08.010","article-title":"Revised diagnostic criteria for neuromyelitis optica.","author":"DM Wingerchuk","year":"2006"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"VA Lennon","year":"2004","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.","volume":"202","author":"VA Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.","volume":"59","author":"BG Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.","volume":"298(1\u20132)","author":"S Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.","volume":"81","author":"A Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","first-page":"78","article-title":"Neuromyelitis optica and non organ-specific autoimmunity.","volume":"65(1)","author":"SJ Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/art.27337","article-title":"Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome.","volume":"62(4)","author":"KP Wandinger","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.","volume":"17(9)","author":"S Jarius","year":"2011","journal-title":"Mult Sclerosis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.","volume":"(7)","author":"S Jarius","year":"2010","journal-title":"Nat Rev Neurol 6"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"(6)","author":"CH Polman","year":"2005","journal-title":"Ann Neurol 58"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/sim.1998","article-title":"Statistical discrimination in the presence of selection effects.","volume":"(8)","author":"RM Hilliam","year":"2005","journal-title":"Stat Med 24"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1148\/radiol.2282011860","article-title":"Measurement of observer agreement.","volume":"228","author":"HL Kundel","year":"2003","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis.","volume":"70","author":"M Matiello","year":"2008","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN\u03b2-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.","volume":"75(16)","author":"J Shimizu","year":"2010","journal-title":"Neurology"},{"key":"ref18","first-page":"1016","article-title":"Interferon Beta Treatment in Neuromyelitis Optica.","volume":"67(8)","author":"J Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica.","volume":"69(2)","author":"I Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1177\/1352458511421185","article-title":"Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.","author":"MH Barnett","year":"2012"},{"key":"ref21","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.","author":"JH Min","year":"2012"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e31822a2780","article-title":"Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.","volume":"77(7)","author":"C Costanzi","year":"2011","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/1352458511404586","article-title":"Impact of rituximab on relapse rate and disability in neuromyelitis optica.","volume":"17(10)","author":"GS Bedi","year":"2011","journal-title":"Mult Scler"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.","volume":"68(11)","author":"SH Kim","year":"2011","journal-title":"Arch Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica.","volume":"64","author":"BA Cree","year":"2005","journal-title":"Neurology"},{"key":"ref26","first-page":"1443","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.","volume":"65","author":"A Jacob","journal-title":"Arch Neurol 2008"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica.","volume":"(13)","author":"S Jarius","year":"2007","journal-title":"Neurology 68"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2010.11.012","article-title":"Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay.","volume":"138","author":"I De Vidi","year":"2011","journal-title":"Clin Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.","volume":"130","author":"T Takahashi","year":"2007","journal-title":"Brain"},{"key":"ref30","first-page":"913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.","volume":"(7)","author":"P Waters","year":"2008","journal-title":"Arch Neurol 65"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.","volume":"4(4)","author":"F Paul","year":"2007","journal-title":"PLoS Med"},{"key":"ref32","first-page":"1134","article-title":"Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.","volume":"66(9)","author":"A McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2008.03.009","article-title":"Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.","author":"S Hayakawa","year":"2008"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458509106851","article-title":"Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.","volume":"(10)","author":"R Fazio","year":"2009","journal-title":"Mult Scler 15"},{"key":"ref35","first-page":"1201","article-title":"Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.","volume":"67(10)","author":"SR Kalluri","year":"2010","journal-title":"Arch Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jneuroim.2009.10.002","article-title":"Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica.","volume":"(1\u20132)","author":"F Marnetto","year":"2009","journal-title":"J Neuroimmunol 217"},{"key":"ref37","first-page":"100","article-title":"Neuromyelitis Optica: Concepts in evolution.J Neuroimmunol","volume":"231(1\u20132)","author":"R Fazio","year":"2010"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.","volume":"11)","author":"S Jarius","year":"2008","journal-title":"Brain 131(Pt"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1352458507084595","article-title":"NMO-IgG and Devic's neuromyelitis optica: a French experience.","volume":"(4)","author":"R Marignier","year":"2008","journal-title":"Mult Scler 14"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: Case report and review of the literature.","volume":"114(4)","author":"S Jarius","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.","volume":"291","author":"S Jarius","year":"2010","journal-title":"J Neurol Sc"},{"key":"ref42","article-title":"Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.","author":"W Kim","year":"2011"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays.","volume":"78(9)","author":"PJ Waters","year":"2012","journal-title":"Neurology"},{"key":"ref44","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70(5):344\u201352.","author":"B Banwell","year":"2008"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1039","DOI":"10.1542\/peds.2007-2758","article-title":"Spectrum of pediatric neuromyelitis optica.","volume":"122(5)","author":"TE Lotze","year":"2008","journal-title":"Pediatrics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T06:59:30Z","timestamp":1540364370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038896"}},"subtitle":[],"editor":[{"given":"Markus","family":"Reindl","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038896","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]}}}